Buscar
ATAI Life Sciences NV
ATAIAñadir a la lista de seguimiento
7.180USD
0.0000.00%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
2.66BCap. mercado
PérdidaP/E TTM
Más Datos de ATAI Life Sciences NV Compañía
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
Información de ATAI Life Sciences NV
Símbolo de cotizaciónATAI
Nombre de la empresaAtai Beckley NV
Fecha de salida a bolsaJun 18, 2021
Director ejecutivoRao (Srinivas G)
Número de empleados54
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
DirecciónProf. J.H.Bavincklaan 7
CiudadAMSTELVEEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísNetherlands
Código postal1183 AT
Teléfono31207932536
Sitio Webhttps://www.atai.com/
Símbolo de cotizaciónATAI
Fecha de salida a bolsaJun 18, 2021
Director ejecutivoRao (Srinivas G)
Ejecutivos de ATAI Life Sciences NV
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+45.68%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
-100.00%
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de ATAI Life Sciences NV?
Los cinco principales accionistas de ATAI Life Sciences NV son: Dr. Glenn Frank Short, Ph.D.
¿Cuántas instituciones poseen acciones de ATAI Life Sciences NV (ATAI)?
A fecha de 2026Q1, 296 instituciones poseen acciones de ATAI Life Sciences NV, con un valor de mercado combinado de aproximadamente 73.07M, lo que representa el 19.93% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 23428346.00.